Federated Hermes, Inc. Rezolute, Inc. Transaction History
Federated Hermes, Inc.
- $41.2 Billion
- Q2 2024
A detailed history of Federated Hermes, Inc. transactions in Rezolute, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 11,279,327 shares of RZLT stock, worth $52.2 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
11,279,327
Previous 10,154,327
11.08%
Holding current value
$52.2 Million
Previous $25.9 Million
87.31%
% of portfolio
0.12%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding RZLT
# of Institutions
53Shares Held
39.3MCall Options Held
1KPut Options Held
0-
Nantahala Capital Management, LLC New Canaan, CT2.99MShares$13.8 Million0.86% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.8MShares$13 Million1.78% of portfolio
-
Adar1 Capital Management, LLC Austin, TX2.06MShares$9.56 Million1.68% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.85MShares$8.57 Million1.08% of portfolio
-
Blackstone Inc New York, NY1.74MShares$8.08 Million0.03% of portfolio
About Rezolute, Inc.
- Ticker RZLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,827,600
- Market Cap $180M
- Description
- Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...